Ligand Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. 

CEO
Todd Christopher Davis
CEOTodd Christopher Davis
Employees
68
Employees68
Headquarters
Jupiter, Florida
HeadquartersJupiter, Florida
Founded
1987
Founded1987
Employees
68
Employees68

LGND Key Statistics

Market cap
3.97B
Market cap3.97B
Price-Earnings ratio
96.68
Price-Earnings ratio96.68
Dividend yield
Dividend yield
Average volume
246.16K
Average volume246.16K
High today
$207.32
High today$207.32
Low today
$200.82
Low today$200.82
Open price
$201.65
Open price$201.65
Volume
233.29K
Volume233.29K
52 Week high
$212.49
52 Week high$212.49
52 Week low
$93.58
52 Week low$93.58

Stock Snapshot

Ligand Pharmaceuticals(LGND) stock is priced at $201.35, giving the company a market capitalization of 3.97B. It carries a P/E multiple of 96.68.

As of 2025-11-17, Ligand Pharmaceuticals(LGND) stock has fluctuated between $200.82 and $207.32. The current price stands at $201.35, placing the stock +0.3% above today's low and -2.9% off the high.

The Ligand Pharmaceuticals(LGND)'s current trading volume is 233.29K, compared to an average daily volume of 246.16K.

In the last year, Ligand Pharmaceuticals(LGND) shares hit a 52-week high of $212.49 and a 52-week low of $93.58.

In the last year, Ligand Pharmaceuticals(LGND) shares hit a 52-week high of $212.49 and a 52-week low of $93.58.

LGND News

The Motley Fool 9h
This Fund Sold $9 Million of Ligand Stock After an 84% Rally — What Investors Should Know

A high-conviction fund just trimmed one of its biggest winners—here’s what long-term investors should make of the move. Ashford Capital Management Inc reported...

This Fund Sold $9 Million of Ligand Stock After an 84% Rally — What Investors Should Know
TipRanks 5d
Major Stock Sales by Ligand Pharma Directors Revealed!

New insider activity at Ligand Pharma ( (LGND) ) has taken place on November 12, 2025. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help y...

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own LGND. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.